THUỐC TÁC DỤNG TRÊN
HỆ CHOLINERGIC
Nguyễn Thùy Dương
1
Thuốc tác dụng trên hệ cholinergic
1. Phân tích được tác dụng, chỉ định, tác dụng không mong
muốn thận trọng/chống chỉ đinh của các thuốc nhóm:
-Chủ vận M N, chủ vận muscarinic, phong bế cholinesterase;
-Ức chế muscarinic, giãn vân
2. So sánh được về chế, tác dụng, ch định, tác dụng
không mong muốn giữa:
-Các thuốc kích thích hệ cholinergic (thuốc chủ vận M N với chủ
vận M, phong bế cholinesterase);
-Mềm cura loại chống khử cực với cura loại khử cực lâu bền
Mục %êu hc tập
2
THUỐC TÁC DỤNG TRÊN HỆ CHOLINERGIC
THUỐC KÍCH THÍCH HỆ CHOLINERGIC
THUỐC ỨC CHẾ HỆ CHOLINERGIC
3
4
Lippincott's Illustrated Reviews: Pharmacology 6th Edn
THUỐC KÍCH THÍCH CHOLINERGIC
5
98 SECTION II Autonomic Drugs
nerves as well as on some tissues that are not innervated by these
nerves, eg, endothelial cells ( Table 7–1 ), and on those tissues
innervated by postganglionic sympathetic cholinergic nerves.
N i c o t i n i c r e c e p t o r s a r e p a r t o f a t r a n s m e m b r a n e p o l y p e p t i d e
whose subunits form cation-selective ion channels (see Figure 2–9 ).
These receptors are located on plasma membranes of postgangli-
onic cells in all autonomic ganglia, of muscles innervated by
somatic motor fibers, and of some central nervous system neurons
(see Figure 6–1 ).
Nonselective cholinoceptor stimulants in sufficient dosage can
produce very diffuse and marked alterations in organ system function
because acetylcholine has multiple sites of action where it initiates
both excitatory and inhibitory effects. Fortunately, drugs are available
that have a degree of selectivity, so that desired effects can often be
achieved while avoiding or minimizing adverse effects.
Selectivity of action is based on several factors. Some drugs
stimulate either muscarinic receptors or nicotinic receptors selec-
tively. Some agents stimulate nicotinic receptors at neuromuscular
junctions preferentially and have less effect on nicotinic receptors
in ganglia. Organ selectivity can also be achieved by using appro-
priate routes of administration (“pharmacokinetic selectivity”).
For example, muscarinic stimulants can be administered topically
to the surface of the eye to modify ocular function while minimiz-
ing systemic effects.
Cholinoceptor stimulants
Nerve
Heart and
smooth muscle
Glands and
endothelium
Alkaloids
Choline esters
Direct-acting
drugs
Neuromuscular
end plate,
skeletal muscle
Nicotinic
Receptors
Muscarinic
ACh Indirect-acting
drugs
Autonomic
ganglion
cells
Reversible
Irreversible
FIGURE 71 The major groups of cholinoceptor-activating drugs, receptors, and target tissues. ACh, acetylcholine.
TABLE 71 Subtypes and characteristics of cholinoceptors.
Receptor Type Other Names Location Structural Features Postreceptor Mechanism
M1Nerves Seven transmembrane segments,
Gq/11 protein-linked
IP3, DAG cascade
M2Cardiac M2Heart, nerves, smooth
muscle
Seven transmembrane segments,
Gi/o protein-linked
Inhibition of cAMP pro-
duction, activation of
K+ channels
M3Glands, smooth muscle,
endothelium
Seven transmembrane segments,
Gq/11 protein-linked
IP3, DAG cascade
M4CNS Seven transmembrane segments, Gi/o
protein-linked
Inhibition of cAMP
production
M5CNS Seven transmembrane segments,
Gq/11 protein-linked
IP3, DAG cascade
NMMuscle type, end plate
receptor
Skeletal muscle neuromus-
cular junction
Pentamer1 [(α1)2β1δγ)] Na+, K+ depolarizing ion
channel
NNNeuronal type, ganglion
receptor
CNS, postganglionic cell
body, dendrites
Pentamer1 with α and β subunits
only, eg, (α4)2(β2)3 (CNS) or
α3α5(β2)3 (ganglia)
Na+, K+ depolarizing ion
channel
1Pentameric structure in Torpedo electric organ and fetal mammalian muscle has two α1 subunits and one each of β1, δ, and γ subunits. The stoichiometry is indicated by sub-
scripts, eg, [(α1) 2 β1 δ γ]. In adult muscle, the γ subunit is replaced by an ε subunit. There are twelve neuronal nicotinic receptors with nine α (α2-α10) subunits and three (β2-β4)
subunits. The subunit composition varies among different mammalian tissues.
DAG, diacylglycerol; IP3, inositol trisphosphate.
Data from Millar NS: Assembly and subunit diversity of nicotinic acetylcholine receptors. Biochem Soc Trans 2003;31:869.
007-Katzung_Ch007_p097-114.indd 98 9/23/11 2:27:23 PM
Basic and Clinical Pharmacology 12th Edn